194 related articles for article (PubMed ID: 21755017)
21. Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members.
Wach S; Schirmacher P; Protschka M; Blessing M
Oncogene; 2001 Nov; 20(53):7761-9. PubMed ID: 11753654
[TBL] [Abstract][Full Text] [Related]
22. IKKalpha is required to maintain skin homeostasis and prevent skin cancer.
Liu B; Xia X; Zhu F; Park E; Carbajal S; Kiguchi K; DiGiovanni J; Fischer SM; Hu Y
Cancer Cell; 2008 Sep; 14(3):212-25. PubMed ID: 18772111
[TBL] [Abstract][Full Text] [Related]
23. Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis.
Cataisson C; Ohman R; Patel G; Pearson A; Tsien M; Jay S; Wright L; Hennings H; Yuspa SH
Cancer Res; 2009 Jan; 69(1):319-28. PubMed ID: 19118017
[TBL] [Abstract][Full Text] [Related]
24. Activation of cutaneous protein kinase C alpha induces keratinocyte apoptosis and intraepidermal inflammation by independent signaling pathways.
Cataisson C; Joseloff E; Murillas R; Wang A; Atwell C; Torgerson S; Gerdes M; Subleski J; Gao JL; Murphy PM; Wiltrout RH; Vinson C; Yuspa SH
J Immunol; 2003 Sep; 171(5):2703-13. PubMed ID: 12928424
[TBL] [Abstract][Full Text] [Related]
25. Critical role of IkappaB kinase alpha in embryonic skin development and skin carcinogenesis.
Zhu F; Park E; Liu B; Xia X; Fischer SM; Hu Y
Histol Histopathol; 2009 Feb; 24(2):265-71. PubMed ID: 19085841
[TBL] [Abstract][Full Text] [Related]
26. CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development.
Macias E; Miliani de Marval PL; De Siervi A; Conti CJ; Senderowicz AM; Rodriguez-Puebla ML
Am J Pathol; 2008 Aug; 173(2):526-35. PubMed ID: 18599613
[TBL] [Abstract][Full Text] [Related]
27. Alterations in cholesterol sulfate and its biosynthetic enzyme during multistage carcinogenesis in mouse skin.
Kiguchi K; Kagehara M; Higo R; Iwamori M; DiGiovanni J
J Invest Dermatol; 1998 Dec; 111(6):973-81. PubMed ID: 9856804
[TBL] [Abstract][Full Text] [Related]
28. CYLD Inhibits the Development of Skin Squamous Cell Tumors in Immunocompetent Mice.
Alameda JP; García-García VA; López S; Hernando A; Page A; Navarro M; Moreno-Maldonado R; Paramio JM; Ramírez Á; García-Fernández RA; Casanova ML
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201751
[TBL] [Abstract][Full Text] [Related]
29. PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition.
Macdonald FH; Yao D; Quinn JA; Greenhalgh DA
Oncogene; 2014 Aug; 33(32):4132-43. PubMed ID: 24037529
[TBL] [Abstract][Full Text] [Related]
30. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of a constitutively active form of c-src in skin epidermis increases sensitivity to tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Matsumoto T; Jiang J; Kiguchi K; Carbajal S; Rho O; Gimenez-Conti I; Beltrán L; DiGiovanni J
Mol Carcinog; 2002 Mar; 33(3):146-55. PubMed ID: 11870880
[TBL] [Abstract][Full Text] [Related]
32. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of SEPA 0009-induced tumorigenesis in v-rasHa transgenic Tg.AC mice.
Fuhrman J; Shafer L; Repertinger S; Chan T; Hansen LA
Toxicol Pathol; 2005; 33(6):623-30. PubMed ID: 16176921
[TBL] [Abstract][Full Text] [Related]
34. Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice.
Afaq F; Saleem M; Krueger CG; Reed JD; Mukhtar H
Int J Cancer; 2005 Jan; 113(3):423-33. PubMed ID: 15455341
[TBL] [Abstract][Full Text] [Related]
35. Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.
Glick AB; Kulkarni AB; Tennenbaum T; Hennings H; Flanders KC; O'Reilly M; Sporn MB; Karlsson S; Yuspa SH
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6076-80. PubMed ID: 7687059
[TBL] [Abstract][Full Text] [Related]
36. IKKalpha, a critical regulator of epidermal differentiation and a suppressor of skin cancer.
Descargues P; Sil AK; Karin M
EMBO J; 2008 Oct; 27(20):2639-47. PubMed ID: 18818691
[TBL] [Abstract][Full Text] [Related]
37. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2.
Pasparakis M; Courtois G; Hafner M; Schmidt-Supprian M; Nenci A; Toksoy A; Krampert M; Goebeler M; Gillitzer R; Israel A; Krieg T; Rajewsky K; Haase I
Nature; 2002 Jun; 417(6891):861-6. PubMed ID: 12075355
[TBL] [Abstract][Full Text] [Related]
38. Role of IKKα in skin squamous cell carcinomas.
Park E; Liu B; Xia X; Zhu F; Jami WB; Hu Y
Future Oncol; 2011 Jan; 7(1):123-34. PubMed ID: 21174543
[TBL] [Abstract][Full Text] [Related]
39. Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis.
Quintanilla M; Ramirez JR; Pérez-Gómez E; Romero D; Velasco B; Letarte M; López-Novoa JM; Bernabéu C
Oncogene; 2003 Sep; 22(38):5976-85. PubMed ID: 12955076
[TBL] [Abstract][Full Text] [Related]
40. A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse.
Trempus CS; Bishop WR; Njoroge FG; Doll RJ; Battalora MS; Mahler JF; Haseman JK; Tennant RW
Mol Carcinog; 2000 Jan; 27(1):24-33. PubMed ID: 10642434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
